GW Pharmaceuticals (GWPH) and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting
Meeting Highlights Include New Phase 3 Data for EPIDIOLEX in Tuberous Sclerosis…
